Skip to main content

Table 1 Patient characteristics based on COVID-19 severity

From: Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis

Study Country (City) Study design Study period Non-severe COVID-19 Severe COVID-19
Age (years) BMI (kg/m2) Dyslipidemia (n) Non-dyslipidemia (n) Age (years) BMI (kg/m2) Dyslipidemia (n) Non-dyslipidemia (n)
Maeda [8] USA (New York) Cohort Mar13–31, 2020 65 [51–77] 28.9 [24.7, 2.3] 64 103 67 [58–76] 27.2 [24.1, 31.8] 28 29
Ferguson [9] USA (California) Cohort Mar13–Apr11, 2020 61.7 [46.6–72.9] NA 17 34 57.6 [42.2–70.1] NA 8 13
Zhang [10] China (Wuhan) Cohort Jan16–Feb3, 2020 51.5 (26–78) NA 5 77 64 (25–87) NA 2 56
To [11] China (Hong Kong) Cohort Jan22–Feb12, 2020 56 (37–75) NA 0 13 66 (39–75) NA 2 8
Rastrelli [12] Italy (Mantua) Cohort NA 63.0 [55.0–66.5] NA 5 16 NA NA 3 7
Almazeedi [13] Kuwait Cohort Feb24–Apr 20, 2020 37.1 ± 16 26.8 ± 7.7 58 996 54.8 ± 11 29.0 ± 5.1 7 35
Chen [14] China (Zhejiang) Cohort Jan1–Mar11, 2020 45.3 ± 13.6 23.20 [21.66–25.71] 0 102 52.8 ± 15.5 24.78 [23.07–26.96] 1 42
Jurado [15] Spain Cohort Second half of March 2020 NA NA 105 286 NA NA 54 108
Wu [16] China (Wuhan) Cohort Dec23, 2019–Feb13, 2020 43.0 [33.0–61.0] NA 11 217 62.0 [52.5–71.5] NA 5 66
Urra [17] Spain Case-
control
Mar1–Apr15, 2020 57.89 ± 13.1 NA 54 91 65.64 ± 14.1 NA 5 22
Gidari [18] Italy (Perugia) Cohort Mar1–Apr20, 2020 63 ± 17 NA 8 33 65 ± 9 NA 2 25
Zhang [19] China (Beijing) Cohort Jan–Feb 2020 45.34 ± 15.25 NA 2 54 64.75 ± 14.76 NA 1 23
de la Rica [20] Spain (Mallorca) Cohort as of Mar 31, 2020 66.30 ± 14.90 NA 16 11 65.57 ± 12.87 NA 13 7
Simonnet [21] France Cohort Feb27–Apr5, 2020 60 [50–72] 27 [25.3–30.8] 10 29 60 [51–69] 31.1 [27.3–37.5] 24 61
Petrilli [22] USA (New York) Cohort Mar1–Apr8, 2020 60 [48–71] NA 692 1047 68 [58–78] NA 465 525
Li [23] China (Wuhan) Case-
control
NA 51.45 ± 15.08 NA 48 376 61.54 ± 13.36 NA 8 91
Chang [24] South Korea (Daegu) Cohort Feb28–Mar 31, 2020 36.47 ± 14.04 NA 4 194 54.08 ± 11.98 NA 2 11
Kong [25] China (Wuhan) Cohort Jan27–Mar9, 2020 53.2 ± 15.6 NA 2 121 67.9 ± 12.3 NA 3 84
Lodigiani [26] Italy (Milan) Cohort Feb13–Apr10, 2020 68 [55–77] NA 69 258 61 [55–69] NA 7 54
  1. Data are expressed as mean ± standard deviation; median [interquartile range]; median (range)
  2. COVID-19 coronavirus disease, NA not available, n number, BMI body mass index